Showing results (131-140 of 468) with videos related to
Sort By:
Pageof 47
Urologic Oncology|May 4, 2012
The risk of biopsy-detectable prostate cancer using the prostate cancer prevention Trial Risk Calculator in a community settingYuanyuan Liang, Donna P Ankerst, Ziding Feng, et al.The Journal of Urology|February 18, 2015
Intermediate-Term Risk of Prostate Cancer is Directly Related to Baseline Prostate Specific Antigen: Implications for Reducing the Burden of Prostate Specific Antigen ScreeningJonathan Gelfond, Kara Choate, Donna P Ankerst, et al.Journal of Personalized Medicine|April 3, 2021
Telomere Length Dynamics and Chromosomal Instability for Predicting Individual Radiosensitivity and Risk via Machine LearningJared J Luxton, Miles J McKenna, Aidan M Lewis, et al.Journal of the National Cancer Institute. Monographs|December 29, 2012
Temporal changes in the clinical approach to diagnosing prostate cancerWilliam M Hilton, Susan S Padalecki, Donna P Ankerst, et al.Cancer|January 11, 2005
Preradiation chemotherapy with methotrexate, cisplatin, 5-fluorouracil, and leucovorin for pediatric nasopharyngeal carcinomaCarlos Rodriguez-Galindo, Marcia Wofford, Robert P Castleberry, et al.Cancer|December 13, 2005
Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increaseAlan R Kristal, Chen Chi, Catherine M Tangen, et al.American Journal of Epidemiology|November 6, 2007
Integrating the predictiveness of a marker with its performance as a classifierMargaret S Pepe, Ziding Feng, Ying Huang, et al.Urology|September 24, 2013
Predicting risk of prostate cancer in men receiving finasteride: effect of prostate volume, number of biopsy cores, and American Urological Association symptom scoreDonna P Ankerst, Cathee Till, Andreas Boeck, et al.Journal of the National Cancer Institute|October 11, 2007
Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidenceRuth D Etzioni, Donna P Ankerst, Noel S Weiss, et al.Medical Care|December 28, 2012
Limitations of basing screening policies on screening trials: The US Preventive Services Task Force and Prostate Cancer ScreeningRuth Etzioni, Roman Gulati, Matt R Cooperberg, et al.Pageof 47